Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

350 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation.
Zewinger S, Reiser J, Jankowski V, Alansary D, Hahm E, Triem S, Klug M, Schunk SJ, Schmit D, Kramann R, Körbel C, Ampofo E, Laschke MW, Selejan SR, Paschen A, Herter T, Schuster S, Silbernagel G, Sester M, Sester U, Aßmann G, Bals R, Kostner G, Jahnen-Dechent W, Menger MD, Rohrer L, März W, Böhm M, Jankowski J, Kopf M, Latz E, Niemeyer BA, Fliser D, Laufs U, Speer T. Zewinger S, et al. Among authors: kostner g. Nat Immunol. 2020 Jan;21(1):30-41. doi: 10.1038/s41590-019-0548-1. Epub 2019 Dec 9. Nat Immunol. 2020. PMID: 31819254
When should we measure lipoprotein (a)?
Kostner KM, März W, Kostner GM. Kostner KM, et al. Eur Heart J. 2013 Nov;34(42):3268-76. doi: 10.1093/eurheartj/eht053. Epub 2013 Jun 4. Eur Heart J. 2013. PMID: 23735860 Review.
Reply to: Apolipoprotein C3 induces inflammasome activation only in its delipidated form.
Zewinger S, Reiser J, Jankowski V, Alansary D, Hahm E, Triem S, Klug M, Schunk SJ, Schmit D, Kramann R, Körbel C, Ampofo E, Laschke MW, Selejan SR, Paschen A, Herter T, Gaul S, Silbernagel G, Sester M, Sester U, Aßmann G, Bals R, Kostner G, Jahnen-Dechent W, Menger MD, Rohrer L, März W, Böhm M, Jankowski J, Kopf M, Latz E, Niemeyer BA, Fliser D, Laufs U, Speer T. Zewinger S, et al. Among authors: kostner g. Nat Immunol. 2023 Mar;24(3):412-413. doi: 10.1038/s41590-023-01424-1. Epub 2023 Feb 13. Nat Immunol. 2023. PMID: 36781986 No abstract available.
Lipoprotein(a): still an enigma?
Kostner KM, Kostner GM. Kostner KM, et al. Curr Opin Lipidol. 2002 Aug;13(4):391-6. doi: 10.1097/00041433-200208000-00006. Curr Opin Lipidol. 2002. PMID: 12151854 Review.
Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia.
Kratzer A, Buchebner M, Pfeifer T, Becker TM, Uray G, Miyazaki M, Miyazaki-Anzai S, Ebner B, Chandak PG, Kadam RS, Calayir E, Rathke N, Ahammer H, Radovic B, Trauner M, Hoefler G, Kompella UB, Fauler G, Levi M, Levak-Frank S, Kostner GM, Kratky D. Kratzer A, et al. Among authors: kostner gm. J Lipid Res. 2009 Feb;50(2):312-26. doi: 10.1194/jlr.M800376-JLR200. Epub 2008 Sep 23. J Lipid Res. 2009. PMID: 18812595 Free PMC article.
[Fibrate in lipid metabolism disorders].
Kostner KM, Kostner GM. Kostner KM, et al. Pharm Unserer Zeit. 2007;36(2):114-9. doi: 10.1002/pauz.200600209. Pharm Unserer Zeit. 2007. PMID: 17424996 Review. German. No abstract available.
350 results